Logo-SPEAC-2.0_Simple
  • About Us
    • About SPEAC
    • Mission and Objectives
    • Project Tasks
    • Team and Partners
  • Tools
    • AESI Lists
    • Case Definitions
    • Companion Guides
    • Vaccine Safety Templates
    • Guidance Documents
    • Living Systematic Reviews
  • Publications
  • DSMB
  • News
Menu
  • About Us
    • About SPEAC
    • Mission and Objectives
    • Project Tasks
    • Team and Partners
  • Tools
    • AESI Lists
    • Case Definitions
    • Companion Guides
    • Vaccine Safety Templates
    • Guidance Documents
    • Living Systematic Reviews
  • Publications
  • DSMB
  • News
MPOX
MARBURG
MPOX
MARBURG

A project from:

Funded in whole by:

Updated Landscape Analysis for Priority List of Adverse Events of Special Interest: Chikunguyna

April 3, 2025

New Companion Guide for Single Organ Cutaneous Vasculitis (SOCV)

January 24, 2025

Validating a proposed case definition for Vaccine-Induced Immune Thrombocytopenia and Thrombosis

December 11, 2024

Report of a SPEAC webinar 22 September 2023: Sensorineural hearing loss, Lassa virus disease and vaccines.

December 3, 2024

Burden of Lassa fever disease in pregnant women and children and options for prevention

November 14, 2024

SPEAC and CEPI members participated in the 23rd annual conference of the International Society of Pharmacovigilance ISoP

October 8, 2024

SPEAC experts join International Neonatal and Maternal Immunization Symposium

April 1, 2024

Women in vaccine safety work to accelerate progress toward vaccine acceptance

March 26, 2024
  • speac-contact@speac-cepi.net
  • About Us
  • Tools
  • Publications
  • DSMB Support
  • News
Linkedin

The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.

© SPEAC 2023. All rights reserved.

  • Privacy Policy
  • Terms and Conditions